Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK, Ndhlovu ZM, Thobakgale-Tshabalala C, Prado JG, Ismail N, Mncube Z, Mkhize L, van der Stok M, Yende N, Walker BD, Goulder PJR, Ndung'u T. Koofhethile CK, et al. Among authors: yende n. J Virol. 2016 Jul 11;90(15):6818-6831. doi: 10.1128/JVI.00276-16. Print 2016 Aug 1. J Virol. 2016. PMID: 27194762 Free PMC article.
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D; CAPRISA 004 Trial Group. Abdool Karim Q, et al. Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19. Science. 2010. PMID: 20643915 Free PMC article. Clinical Trial.
Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial.
Karim QA, Kharsany AB, Frohlich JA, Baxter C, Yende N, Mansoor LE, Mlisana KP, Maarschalk S, Arulappan N, Grobler A, Sibeko S, Omar Z, Gengiah TN, Mlotshwa M, Samsunder N, Karim SS. Karim QA, et al. Among authors: yende n. Trials. 2011 Mar 7;12:67. doi: 10.1186/1745-6215-12-67. Trials. 2011. PMID: 21385354 Free PMC article. Clinical Trial.
Neurodevelopmental outcomes of HIV/antiretroviral drug perinatally exposed uninfected children aged 3-6 years.
Fowler MG, Hanrahan C, Yende N, Stranix-Chibanda L, Chipato T, Maliwichi L, Gadama L, Aizire J, Dadabhai S, Chinula L, Wambuzi-Owang L, Owor M, Violari A, Nyati M, Hanley S, Govender V, Brummel S, Taha T. Fowler MG, et al. Among authors: yende n. AIDS. 2022 Sep 1;36(11):1533-1543. doi: 10.1097/QAD.0000000000003290. Epub 2022 Jun 22. AIDS. 2022. PMID: 35730383 Free PMC article.
Diagnostic Accuracy of Chest X-ray Computer-Aided Detection Software for Detection of Prevalent and Incident Tuberculosis in Household Contacts.
Macpherson L, Kik SV, Quartagno M, Lakay F, Jaftha M, Yende N, Galant S, Aziz S, Daroowala R, Court R, Taliep A, Serole K, Goliath RT, Davies NO, Jackson A, Douglass E, Sossen B, Mukasa S, Thienemann F, Song T, Ruhwald M, Wilkinson RJ, Coussens AK, Esmail H; Imaging of TB Household Contacts Group. Macpherson L, et al. Among authors: yende n. Clin Infect Dis. 2024 Dec 18:ciae528. doi: 10.1093/cid/ciae528. Online ahead of print. Clin Infect Dis. 2024. PMID: 39692469
A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing.
Verma R, da Silva KE, Rockwood N, Wasmann RE, Yende N, Song T, Kim E, Denti P, Wilkinson RJ, Andrews JR. Verma R, et al. Among authors: yende n. medRxiv [Preprint]. 2023 Sep 10:2023.09.08.23295248. doi: 10.1101/2023.09.08.23295248. medRxiv. 2023. Update in: Am J Respir Crit Care Med. 2024 Jun 15;209(12):1486-1496. doi: 10.1164/rccm.202309-1583OC PMID: 37732197 Free PMC article. Updated. Preprint.
23 results